blade air mobility inc. - BLDE
BLDE
Close Chg Chg %
3.21 0.09 2.80%
Closed Market
3.30
+0.09 (2.80%)
Volume: 779.02K
Last Updated:
Nov 21, 2024, 4:00 PM EDT
Company Overview: blade air mobility inc. - BLDE
BLDE Key Data
| Open $3.24 | Day Range 3.21 - 3.38 |
| 52 Week Range 2.45 - 4.25 | Market Cap $251.39M |
| Shares Outstanding 78.31M | Public Float 55.94M |
| Beta 1.05 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.68 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 627.58K |
BLDE Performance
| 1 Week | 4.43% | ||
| 1 Month | -6.78% | ||
| 3 Months | 5.77% | ||
| 1 Year | -2.08% | ||
| 5 Years | N/A |
BLDE Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
4
Full Ratings ➔
About blade air mobility inc. - BLDE
Blade Air Mobility, Inc. engages in providing air transportation alternatives through a technology-powered and global air mobility platform. It operates through the Passenger and Medical segments. The Passenger segment includes short distance helicopter and amphibious seaplane flights and non-medical jet charter. The Medical segment is involved in the transportation of human organs for transplant. The company was founded by Robert S. Wiesenthal and Steven Martocci on December 22, 2014 and is headquartered in New York, NY.
BLDE At a Glance
Blade Air Mobility, Inc.
55 Hudson Yards
New York, New York 10001
| Phone | 1-212-967-1009 | Revenue | 225.18M | |
| Industry | Airlines | Net Income | -56,076,000.00 | |
| Sector | Transportation | 2023 Sales Growth | 54.106% | |
| Fiscal Year-end | 12 / 2024 | Employees | 281 | |
| View SEC Filings |
BLDE Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1.153 |
| Price to Book Ratio | 1.132 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.914 |
| Enterprise Value to Sales | 0.519 |
| Total Debt to Enterprise Value | 0.21 |
BLDE Efficiency
| Revenue/Employee | 801,352.313 |
| Income Per Employee | -199,558.719 |
| Receivables Turnover | 10.72 |
| Total Asset Turnover | 0.726 |
BLDE Liquidity
| Current Ratio | 5.812 |
| Quick Ratio | 5.812 |
| Cash Ratio | 4.713 |
BLDE Profitability
| Gross Margin | 16.025 |
| Operating Margin | -30.25 |
| Pretax Margin | -25.554 |
| Net Margin | -24.903 |
| Return on Assets | -18.09 |
| Return on Equity | -22.043 |
| Return on Total Capital | -21.666 |
| Return on Invested Capital | -20.635 |
BLDE Capital Structure
| Total Debt to Total Equity | 10.467 |
| Total Debt to Total Capital | 9.476 |
| Total Debt to Total Assets | 8.315 |
| Long-Term Debt to Equity | 8.424 |
| Long-Term Debt to Total Capital | 7.626 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Blade Air Mobility Inc. - BLDE
Collapse All in section
| All values USD millions. | 2019 | 2021 | 2022 | 2023 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| - | 50.53M | 146.12M | 225.18M | |
Sales Growth
| - | - | +189.20% | +54.11% | - |
Cost of Goods Sold (COGS) incl D&A
| - | 39.96M | 128.74M | 189.09M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| - | 596.00K | 5.72M | 7.11M | |
Depreciation
| - | 353.00K | 830.00K | 1.07M | |
Amortization of Intangibles
| - | 243.00K | 4.89M | 6.04M | |
COGS Growth
| - | - | +222.14% | +46.88% | - |
Gross Income
| - | 10.56M | 17.38M | 36.09M | |
Gross Income Growth
| - | - | +64.55% | +107.63% | - |
Gross Profit Margin
| - | +20.90% | +11.89% | +16.03% |
| 2019 | 2021 | 2022 | 2023 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| - | 34.66M | 67.88M | 104.20M | |
Research & Development
| - | 1.51M | 5.54M | 4.63M | |
Other SG&A
| - | 33.14M | 62.33M | 99.58M | |
SGA Growth
| - | - | +95.86% | +53.52% | - |
Other Operating Expense
| - | - | - | 268.21K | - |
Unusual Expense
| - | 20.06M | (21.19M) | (2.13M) | |
EBIT after Unusual Expense
| (268.21K) | (44.16M) | (29.30M) | (65.99M) | |
Non Operating Income/Expense
| 1.26M | 472.00K | 1.27M | 8.45M | |
Non-Operating Interest Income
| 1.26M | 472.00K | 3.43M | 8.44M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| - | - | - | 12.00K | - |
Interest Expense Growth
| - | - | - | -100.00% | - |
Gross Interest Expense
| - | - | - | 12.00K | - |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 993.39K | (43.70M) | (28.03M) | (57.54M) | |
Pretax Income Growth
| - | -4,498.57% | +35.85% | -105.27% | |
Pretax Margin
| - | -86.48% | -19.18% | -25.55% | |
Income Tax
| 208.61K | (3.64M) | (772.00K) | (1.47M) | |
Income Tax - Current - Domestic
| - | - | - | 208.61K | - |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| - | - | (3.64M) | (144.00K) | - |
Income Tax - Deferred - Foreign
| - | - | (628.00K) | (1.47M) | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 784.78K | (40.05M) | (27.26M) | (56.08M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 784.78K | (40.05M) | (27.26M) | (56.08M) | |
Net Income Growth
| - | -5,203.61% | +31.94% | -105.71% | |
Net Margin Growth
| - | -79.27% | -18.66% | -24.90% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 784.78K | (40.05M) | (27.26M) | (56.08M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 784.78K | (40.05M) | (27.26M) | (56.08M) | |
EPS (Basic)
| 0.0235 | -0.934 | -0.3827 | -0.7627 | |
EPS (Basic) Growth
| - | -4,074.47% | +59.03% | -99.29% | |
Basic Shares Outstanding
| 33.35M | 42.88M | 71.24M | 73.52M | |
EPS (Diluted)
| 0.0235 | -0.934 | -0.3827 | -0.7627 | |
EPS (Diluted) Growth
| - | -4,074.47% | +59.03% | -99.29% | |
Diluted Shares Outstanding
| 33.35M | 42.88M | 71.24M | 73.52M | |
EBITDA
| (268.21K) | (23.50M) | (44.77M) | (61.01M) | |
EBITDA Growth
| - | -8,660.67% | -90.54% | -36.26% | |
EBITDA Margin
| - | -46.50% | -30.64% | -27.09% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 7.625 | |
| Number of Ratings | 4 | Current Quarters Estimate | -0.103 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | -0.33 | |
| Last Quarter’s Earnings | -0.03 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.626 | Next Fiscal Year Estimate | -0.219 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 3 | N/A | 3 | 3 |
| Mean Estimate | -0.10 | N/A | -0.33 | -0.22 |
| High Estimates | -0.08 | N/A | -0.30 | -0.19 |
| Low Estimate | -0.12 | N/A | -0.35 | -0.26 |
| Coefficient of Variance | -20.20 | N/A | -8.02 | -16.70 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 5 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Blade Air Mobility Inc. - BLDE
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Blade Air Mobility Inc. - BLDE
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Sep 13, 2024 | Robert S. Wiesenthal Chief Executive Officer; Director | 6,912,892 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.85 per share | 19,701,742.20 |
| Sep 13, 2024 | Scott Wunsch CEO, Trinity Air Medical | 284,962 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $2.85 per share | 812,141.70 |
| Aug 16, 2024 | William A. Heyburn Chief Financial Officer | 1,410,586 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.18 per share | 253,905.48 |
| Aug 16, 2024 | William A. Heyburn Chief Financial Officer | 225,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 18, 2024 | Seth J Bacon CEO, Trinity Air Medical | 340,785 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.94 per share | 1,001,907.90 |
| Jun 18, 2024 | Melissa M. Tomkiel President and General Counsel | 1,251,642 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.94 per share | 3,679,827.48 |
| Jun 18, 2024 | Amir M. Cohen Chief Accounting Officer | 79,482 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.94 per share | 233,677.08 |
| Jun 13, 2024 | Borthwick John Director | 83,817 | Open market or private purchase of non-derivative security Non-derivative transaction at $2.97 per share | 248,936.49 |
| Jun 13, 2024 | Reginald L. Love Director | 62,628 | Open market or private purchase of non-derivative security Non-derivative transaction at $2.98 per share | 186,631.44 |
| Jun 13, 2024 | Melissa M. Tomkiel President and General Counsel | 6,264 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 18, 2024 | Seth J Bacon CEO, Trinity Air Medical | 342,201 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $3.94 per share | 1,348,271.94 |
| Mar 18, 2024 | Seth J Bacon CEO, Trinity Air Medical | 342,381 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $2.62 per share | 897,038.22 |
| Mar 18, 2024 | Amir M. Cohen Chief Accounting Officer | 99,602 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $2.62 per share | 260,957.24 |
| Mar 18, 2024 | Melissa M. Tomkiel President and General Counsel | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 18, 2024 | Melissa M. Tomkiel President and General Counsel | 44,374 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 18, 2024 | Melissa M. Tomkiel President and General Counsel | 1,286,100 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.18 per share | 231,498.00 |
| Mar 18, 2024 | Melissa M. Tomkiel President and General Counsel | 1,277,032 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.18 per share | 229,865.76 |
| Mar 18, 2024 | William A. Heyburn Chief Financial Officer | 325,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 18, 2024 | William A. Heyburn Chief Financial Officer | 1,380,020 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.18 per share | 248,403.60 |
| Mar 18, 2024 | Robert S. Wiesenthal Chief Executive Officer; Director | 7,174,911 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $2.62 per share | 18,798,266.82 |